GLP-1 Coverage Insights
Coverage for GLP-1 medications varies significantly across high-income countries, with many denying reimbursement for weight management despite widespread support for diabetes treatment. Countries like France and the UK emphasize a holistic approach, linking drug access to lifestyle changes and weight loss results. In stark contrast, the U.S. faces exorbitant prices, showcasing the flexibility of drug pricing based on governmental policies and market demands.In this clip
From this podcast
Freakonomics Radio
615. Is Ozempic as Magical as It Sounds? | Freakonomics Radio
Related Questions